Dapagliflozin | High-Quality Pharmaceutical Reference Standard
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus, heart failure, and chronic kidney disease. It lowers blood glucose levels by promoting urinary glucose excretion and provides additional cardio-renal benefits. Dapagliflozin API is manufactured under GMP conditions and is suitable for oral tablet formulations.
Dapagliflozin API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 17
